MedTrace Logo

Successful Pregnancy and Delivery After AOA

NCT01595815 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-05-09

No results posted yet for this study

Summary

Artificial oocyte activation with strontium chloride or calcium ionophore improves fertilization, embryo quality, pregnancy and delivery rate in women who showed complete fertilization failure or low fertilization rates

Conditions

Interventions

OTHER

Calcium ionophore

Oocytes were activated with calcium ionophore after ICSI

OTHER

Strontium chloride (SrCl2)

Oocytes were activated with strontium chloride after ICSI

Sponsors & Collaborators

  • Maria Fertility Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2011-09-30
Completion
2014-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01595815 on ClinicalTrials.gov